Frank Policht

Company: Genmab

Job title: Director - Diagnostics & Biomarker Development

Bio:

Frank Policht is currently Director of Diagnostics and Biomarker Development at Genmab, where he leads biomarker strategy and diagnostic development to support precision medicine approaches in oncology drug development. With over two decades of experience across diagnostic assay development, biomarker implementation, and strategic biopharma partnerships where his work has spanned translational research, commercial strategy, and global medical education. Frank has authored or co-authored multiple peer-reviewed publications in oncology and pathology, including studies on EGFR amplification, ALK/ROS1 rearrangements in lung cancer and the evolution of precision medicine. He brings a unique blend of scientific expertise and business acumen to initiatives that bridge diagnostics with therapeutic development.

Seminars:

Panel Discussion: Driving Patient Selection with Digital Pathology for Streamlined Clinical Trials 9:30 am

How can digital pathology improve the identification and stratification of patients for biomarker-driven therapies, and where is it already making a measurable impact? What steps should biopharma take to integrate digital pathology into trial design early, so it meaningfully contributes to patient enrichment, rather than becoming an afterthought? What are the key considerations when validating…Read more

day: Conference Day Two